Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 5 mg/850 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy® 5 mg/850 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)

Clinical trial NCT06766500 · COMPLETED

Trial details

NCT number: NCT06766500
Sponsor: Gedeon Richter Plc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2025-01-20
Primary completion: 2025-02-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.